{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:32:09Z","timestamp":1787632329627,"version":"build-2736575974"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":274,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Danmarks Tekniske University","award":["Alliance 102140"],"award-info":[{"award-number":["Alliance 102140"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human autoimmune diseases are complex and highly diverse conditions that can be of localised or systemic nature. Understanding the basic biology of autoimmune diseases goes hand in hand with providing the clinics with valuable biomarkers for managing these diseases. The focus of this review is paid to localised scleroderma, an autoimmune disease affecting skin and subcutaneous tissue. Localised scleroderma has very few serological biomarkers for clinical analyses distinguishing it from main differentials, and yet noneffective prognostic biomarkers. With this regard, the review covers well-established and new biomarkers such as cell surface proteins, autoantibodies and cytokines. In recent few years, several new biomarkers have been suggested, many provided with modern genomic studies. This includes epigenetic regulation of DNA, RNA transcriptomics and regulatory RNA such as microRNA and long non-coding RNA. These findings can for the first time shed light on the genetic mechanisms behind the disease and contribute to improved diagnosis and treatment.<\/jats:p>","DOI":"10.1002\/ski2.335","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T05:39:56Z","timestamp":1705037996000},"source":"Crossref","is-referenced-by-count":4,"title":["Biomarkers in Skin Autoimmunity\u2014An Update on Localised Scleroderma"],"prefix":"10.1093","volume":"4","author":[{"given":"Adri\u00e1n","family":"Hern\u00e1ndez-Bustos","sequence":"first","affiliation":[{"name":"Department of Chemistry, Technical University of Denmark , Kongens, Lyngby ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begona","family":"Bolos","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Technical University of Denmark , Kongens, Lyngby ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-0301","authenticated-orcid":false,"given":"Kira","family":"Astakhova","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Technical University of Denmark , Kongens, Lyngby ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2025112605121337800_ski2335-bib-0001","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7403796","article-title":"Regulation of inflammation in autoimmune diseases","author":"Rao","year":"2019","journal-title":"J Immunol Res"},{"key":"2025112605121337800_ski2335-bib-0002","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01525","article-title":"The role of epigenetics in autoimmune\/inflammatory disease","volume":"10","author":"Surace","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"2025112605121337800_ski2335-bib-0003","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0004","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.BOR.0000245727.40630.C3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2025112605121337800_ski2335-bib-0005","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/JAMADERMATOL.2020.5809","article-title":"An evaluation of the performance of current morphea subtype classifications","volume":"157","author":"Prasad","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"11","key":"2025112605121337800_ski2335-bib-0006","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/art.38814","article-title":"Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the morphea in adults and children cohort","volume":"66","author":"Jacobe","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"2025112605121337800_ski2335-bib-0007","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1684\/EJD.2014.2384","article-title":"Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients","volume":"24","author":"Makino","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0008","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features","volume":"55","author":"Kurzinski","year":"2011","journal-title":"Cytokine"},{"key":"2025112605121337800_ski2335-bib-0009","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2023.1108623","article-title":"Morphea: the 2023 update","volume":"10","author":"Papara","year":"2023","journal-title":"Front Med"},{"key":"2025112605121337800_ski2335-bib-0010","volume-title":"Morphea, StatPearls","author":"Penmetsa","year":"2023"},{"issue":"5","key":"2025112605121337800_ski2335-bib-0011","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/ARCHDERM.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients","volume":"130","author":"Joly","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0012","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2025112605121337800_ski2335-bib-0013","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0014","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/S12016-020-08831-4","article-title":"Clinical treatment options in scleroderma: recommendations and comprehensive review","volume":"62","author":"Zhao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025112605121337800_ski2335-bib-0015","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S40674-021-00170-5","article-title":"Evaluation and treatment of pediatric localized scleroderma: pearls and updates","volume":"7","author":"Glaser","year":"2021","journal-title":"Curr Treat Options Rheumatol"},{"issue":"12","key":"2025112605121337800_ski2335-bib-0016","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1093\/RHEUMATOLOGY\/KEAB238","article-title":"Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"2025112605121337800_ski2335-bib-0017","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ART.24339","article-title":"Scleroderma prevalence: demographic variations in a population-based sample","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Care Res"},{"issue":"10","key":"2025112605121337800_ski2335-bib-0018","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/art.41758","article-title":"Transcriptomic evaluation of juvenile localized scleroderma skin with histologic and clinical correlation","volume":"73","author":"Schutt","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0019","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","volume":"14","author":"Kreuter","year":"2016","journal-title":"J Ger Soc Dermatol"},{"issue":"7","key":"2025112605121337800_ski2335-bib-0020","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1346-8138.14161","article-title":"Diagnostic criteria, severity classification and guidelines of localized scleroderma","volume":"45","author":"Asano","year":"2018","journal-title":"J Dermatol"},{"issue":"7","key":"2025112605121337800_ski2335-bib-0021","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/1346-8138.15368","article-title":"Ultraviolet A1 phototherapy for the treatment of localized scleroderma","volume":"47","author":"Furuhashi","year":"2020","journal-title":"J Dermatol"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0022","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/1346-8138.14713","article-title":"Comparison of 2-D shear wave elastography with clinical score in localized scleroderma: a new method to increase the diagnostic accuracy","volume":"46","author":"Wang","year":"2019","journal-title":"J Dermatol"},{"issue":"12","key":"2025112605121337800_ski2335-bib-0023","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1016\/j.ultrasmedbio.2020.08.007","article-title":"Feasibility of using elastography ultrasound in pediatric localized scleroderma (morphea)","volume":"46","author":"P\u00e9rez","year":"2020","journal-title":"Ultrasound Med Biol"},{"issue":"8","key":"2025112605121337800_ski2335-bib-0024","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","article-title":"Consensus-based recommendations for the management of juvenile localised scleroderma","volume":"78","author":"Zulian","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0025","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamadermatol.2014.2668","article-title":"In vivo high-definition optical coherence tomography: a bedside diagnostic aid for morphea","volume":"151","author":"Su","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0026","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpeds.2006.04.052","article-title":"Congenital localized scleroderma","volume":"149","author":"Zulian","year":"2006","journal-title":"J Pediatr"},{"issue":"4","key":"2025112605121337800_ski2335-bib-0027","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis","volume":"65","author":"Li","year":"2018","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"2025112605121337800_ski2335-bib-0028","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Simmonds","year":"2007","journal-title":"Curr Genom"},{"key":"2025112605121337800_ski2335-bib-0029","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis - PubMed","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0030","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/IJD.15811","article-title":"Localized scleroderma: actual insights and new biomarkers","volume":"61","author":"Snarskaya","year":"2022","journal-title":"Int J Dermatol"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0031","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/IEP.12456","article-title":"Skin fibrosis associated with keloid, scleroderma and Jorge Lobo\u2019s disease (lacaziosis): an immuno-histochemical study","volume":"103","author":"Tafuri","year":"2022","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"2025112605121337800_ski2335-bib-0032","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/S40257-013-0027-7","article-title":"Pulsed dye laser in the treatment of localized scleroderma and its effects on CD34+ and factor XIIIa+ cells: an immunohistochemical study","volume":"14","author":"Tawfik","year":"2013","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"2025112605121337800_ski2335-bib-0033","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/J.1365-4632.2008.03615.X","article-title":"Immunohistochemical characterization of the cellular infiltrate in localized scleroderma","volume":"47","author":"Xie","year":"2008","journal-title":"Int J Dermatol"},{"key":"2025112605121337800_ski2335-bib-0034","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1684\/EJD.2008.0310","article-title":"Expression of CD1a and CD86 on scleroderma Langerhans cells","volume":"18","author":"Xie","year":"2008","journal-title":"Eur J Dermatol"},{"key":"2025112605121337800_ski2335-bib-0035","first-page":"698","article-title":"Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease","volume":"27","author":"Ihn","year":"2000","journal-title":"J Rheumatol"},{"key":"2025112605121337800_ski2335-bib-0036","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2230.2005.01776.x","article-title":"Rheumatoid factor isotypes in localized scleroderma","volume":"30","author":"Mimura","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"2025112605121337800_ski2335-bib-0037","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology"},{"key":"2025112605121337800_ski2335-bib-0038","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025112605121337800_ski2335-bib-0039","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/acr2.1019","article-title":"Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and Rheumatology research alliance legacy registry","volume":"1","author":"Wu","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"2025112605121337800_ski2335-bib-0040","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"2025112605121337800_ski2335-bib-0041","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/bjd.17312","article-title":"Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma","volume":"180","author":"Kurzinski","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025112605121337800_ski2335-bib-0042","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semarthrit.2015.06.006.Peripheral","article-title":"Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell associated cytokine profiles","volume":"45","author":"Torok","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2025112605121337800_ski2335-bib-0043","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"2025112605121337800_ski2335-bib-0044","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jid.2016.02.033","article-title":"Identification of cytokine biomarkers in morphea","volume":"136","author":"O\u2019Brien","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2025112605121337800_ski2335-bib-0045","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaut.2019.04.008","article-title":"The identification of CCL18 as biomarker of disease activity in localized scleroderma","volume":"101","author":"Mertens","year":"2019","journal-title":"J Autoimmun"},{"key":"2025112605121337800_ski2335-bib-0046","doi-asserted-by":"publisher","first-page":"S270","DOI":"10.1016\/j.jid.2017.07.652","article-title":"Secreted protein acidic and Rich in cysteine, a new biomarker of localized scleroderma","volume":"137","author":"Tsuruta","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2025112605121337800_ski2335-bib-0047","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jid.2018.03.031","article-title":"Myelin basic protein antibodies as a biomarker in morphea","volume":"138","author":"Burger","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2025112605121337800_ski2335-bib-0048","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-022-03246-5","article-title":"Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea","volume":"20","author":"Zhu","year":"2022","journal-title":"J Transl Med"},{"key":"2025112605121337800_ski2335-bib-0049","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.14458","article-title":"European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes","volume":"31","author":"Knobler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025112605121337800_ski2335-bib-0050","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clindermatol.2018.04.005","article-title":"Morphea: current concepts","volume":"36","author":"Florez-Pollack","year":"2018","journal-title":"Clin Dermatol"},{"issue":"10","key":"2025112605121337800_ski2335-bib-0051","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","article-title":"Morphea in adults and children cohort III: nested case-control study - the clinical significance of autoantibodies in morphea","volume":"149","author":"Warner Dharamsi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2025112605121337800_ski2335-bib-0052","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01487","article-title":"Autoantibodies in morphea: an update","volume":"10","author":"Khatri","year":"2019","journal-title":"Front Immunol"},{"key":"2025112605121337800_ski2335-bib-0053","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/J.BIOPHA.2018.09.090","article-title":"MicroRNAs as biological regulators in skin disorders","volume":"108","author":"Singhvi","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2025112605121337800_ski2335-bib-0054","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/J.GPB.2015.07.001","article-title":"MicroRNAs regulating signaling pathways: potential biomarkers in systemic sclerosis, genomics","volume":"13","author":"Li","year":"2015","journal-title":"Proteom Bioinformat"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0055","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/S40291-017-0294-8","article-title":"MicroRNA-21 in skin fibrosis: potential for diagnosis and treatment","volume":"21","author":"Li","year":"2017","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"2025112605121337800_ski2335-bib-0056","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/14728222.2012.708339","article-title":"MicroRNA-29: a potential therapeutic target for systemic sclerosis","volume":"16","author":"Peng","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"2025112605121337800_ski2335-bib-0057","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/J.JAUT.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J Autoimmun"},{"issue":"1","key":"2025112605121337800_ski2335-bib-0058","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/S00403-012-1287-4","article-title":"microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma","volume":"305","author":"Etoh","year":"2013","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0059","doi-asserted-by":"publisher","first-page":"208","DOI":"10.23736\/S0392-0488.18.05922-9","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"Rongioletti","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0060","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/03009742.2019.1641615","article-title":"Immunoglobulin G galactosylation levels are decreased in systemic sclerosis patients and differ according to disease subclassification","volume":"49","author":"Liu","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"2025112605121337800_ski2335-bib-0061","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2021.669116\/FULL","article-title":"Genetic signatures from RNA sequencing of pediatric localized scleroderma skin","volume":"9","author":"Mirizio","year":"2021","journal-title":"Front Pediatr"},{"issue":"8","key":"2025112605121337800_ski2335-bib-0062","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J Immunol"},{"issue":"s6","key":"2025112605121337800_ski2335-bib-0063","doi-asserted-by":"publisher","DOI":"10.1111\/J.1610-0387.2009.07178.X","article-title":"Diagnosis and therapy of localized scleroderma","volume":"7","author":"Kreuter","year":"2009","journal-title":"J Der Dtsch Dermatol Ges"},{"issue":"8b","key":"2025112605121337800_ski2335-bib-0064","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/J.1582-4934.2008.00401.X","article-title":"Surface morphology and mechanical properties of fibroblasts from scleroderma patients","volume":"13","author":"Reich","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2025112605121337800_ski2335-bib-0065","doi-asserted-by":"publisher","DOI":"10.1007\/S11926-012-0304-0","article-title":"Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities","volume":"15","author":"Iwayama","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"37","key":"2025112605121337800_ski2335-bib-0066","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2306965120","article-title":"IL-6 trans-signaling in a humanized mouse model of scleroderma","volume":"120","author":"Odell","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0067","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5114\/ADA.2018.77613","article-title":"The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma","volume":"35","author":"Wodok-Wieczorek","year":"2018","journal-title":"Postep Dermatol Alergol"},{"issue":"1","key":"2025112605121337800_ski2335-bib-0068","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/18743129014090100030","article-title":"A case report of successful treatment of recalcitrant childhood localized scleroderma with infliximab and leflunomide","volume":"9","author":"Ferguson","year":"2015","journal-title":"Open Rheumatol J"},{"issue":"3","key":"2025112605121337800_ski2335-bib-0069","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3928\/0090-4481-20050301-11","article-title":"Connective tissue disease in children","volume":"34","author":"Buka","year":"2005","journal-title":"Pediatr Ann"},{"issue":"7","key":"2025112605121337800_ski2335-bib-0070","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/S00403-023-02541-5","article-title":"Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies","volume":"315","author":"Saracino","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"2025112605121337800_ski2335-bib-0071","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.18632\/ONCOTARGET.13629","article-title":"Targeting the VEGF-C\/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS\/YAP1 signaling","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"2025112605121337800_ski2335-bib-0072","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/art.30312","article-title":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?","volume":"63","author":"Wei","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025112605121337800_ski2335-bib-0073","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLIM.2021.108756","article-title":"DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma","volume":"228","author":"Coit","year":"2021","journal-title":"Clin Immunol"},{"issue":"1","key":"2025112605121337800_ski2335-bib-0074","doi-asserted-by":"publisher","DOI":"10.1186\/S13075-020-02343-4","article-title":"Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma","volume":"22","author":"Mirizio","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"2025112605121337800_ski2335-bib-0075","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1111\/JOCD.15318","article-title":"Identification of lncRNA expression profiles in pediatric localized scleroderma","volume":"21","author":"Gong","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2025112605121337800_ski2335-bib-0076","volume-title":"Nct, riociguat in scleroderma associated digital ulcers","year":"2016"},{"key":"2025112605121337800_ski2335-bib-0077","volume-title":"N.L. of M. of the U. government NIH, morphea in adults and children (MAC) cohort study: a morphea registry and DNA repository | ClinicalTrials.gov"},{"key":"2025112605121337800_ski2335-bib-0078","volume-title":"N.L. of M. of the U. government NIH, microRNAs in Systemic Scleroderma | ClinicalTrials.gov"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/2\/ski2.335\/59729869\/skinhd_4_2_e335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/2\/ski2.335\/59729869\/skinhd_4_2_e335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:12:21Z","timestamp":1764151941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.335\/7736676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.335","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,12]]},"article-number":"ski2.335"}}